FSMAX
Price
$101.54
Change
-$1.22 (-1.19%)
Updated
Oct 7 closing price
Net Assets
41.44B
LMOFX
Price
$47.68
Change
-$0.32 (-0.67%)
Updated
Oct 7 closing price
Net Assets
1.82B
Interact to see
Advertisement

FSMAX vs LMOFX

Header iconFSMAX vs LMOFX Comparison
Open Charts FSMAX vs LMOFXBanner chart's image
Fidelity Extended Market Index
Price$101.54
Change-$1.22 (-1.19%)
VolumeN/A
Net Assets41.44B
Patient Opportunity FI
Price$47.68
Change-$0.32 (-0.67%)
VolumeN/A
Net Assets1.82B
FSMAX vs LMOFX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. LMOFX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and LMOFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.4B vs. LMOFX (1.82B). FSMAX pays higher dividends than LMOFX: FSMAX (0.44) vs LMOFX (0.00). FSMAX was incepted earlier than LMOFX: FSMAX (14 years) vs LMOFX (22 years). LMOFX (1.83) is less costly to investors than FSMAX (0.04). LMOFX is a more actively managed with annual turnover of: 31.00 vs. FSMAX (9.00). FSMAX (0) and LMOFX (0) have matching initial minimum investment requirements. LMOFX annual gain was more profitable for investors over the last year : 32.56 vs. FSMAX (19.58). FSMAX return over 5 years is better than : 53.17 vs. LMOFX (47.33).
FSMAXLMOFXFSMAX / LMOFX
Total Expense Ratio0.041.822%
Annual Report Gross Expense Ratio0.041.832%
Fund Existence14 years22 years-
Gain YTD13.07221.76660%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets41.4B1.82B2,276%
Annual Yield % from dividends0.440.00-
Returns for 1 year19.5832.5660%
Returns for 3 years70.0282.1685%
Returns for 5 years53.1747.33112%
Returns for 10 years107.23133.4680%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDNMY12.30N/A
N/A
Edenred Malakoff
PTPIF0.53N/A
N/A
PT Chandra Asri Pacific Tbk
CSTAF11.52N/A
N/A
Constellation Acquisition Corp I
MAOFF1.61N/A
N/A
MAOYAN ENTMT
CSCIF2.55-0.14
-5.13%
COSCIENS Biopharma Inc